28036-31-9 Usage
Uses
Used in Pharmaceutical Development:
2-Methylimidazo[1,2-a]pyridin-3-amine is utilized as a key component in the development of pharmaceutical drugs due to its unique chemical structure and potential therapeutic effects. Its presence in drug formulations is attributed to its ability to interact with specific biological targets, which may contribute to the treatment of various diseases.
Used in Cancer Treatment Research:
In the field of oncology, 2-Methylimidazo[1,2-a]pyridin-3-amine is studied for its potential as an anticancer agent. 2-METHYLIMIDAZO[1,2-A]PYRIDIN-3-AMINE's interactions with cellular and molecular targets are of particular interest, as they may provide insights into the development of novel cancer therapies.
Used in Neurological Disorder Research:
2-Methylimidazo[1,2-a]pyridin-3-amine is also being investigated for its possible role in the treatment of neurological disorders. Its unique properties may offer new avenues for understanding and managing such conditions, making it a valuable subject of research in neurochemistry and related fields.
Check Digit Verification of cas no
The CAS Registry Mumber 28036-31-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,0,3 and 6 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 28036-31:
(7*2)+(6*8)+(5*0)+(4*3)+(3*6)+(2*3)+(1*1)=99
99 % 10 = 9
So 28036-31-9 is a valid CAS Registry Number.
28036-31-9Relevant academic research and scientific papers
Chaouni-Benabdallah, Aziz,Galtier, Christophe,Allouchi, Hassan,Kherbeche, Abdelak,Chavignon, Olivier,Teulade, Jean-Claude,Witvrouw, Myriam,Pannecouque, Christophe,Snoeck, Robert,Andrei, Graciela,Balzarini, Jan,De Clercq, Erik,Fauvelle, Florence,Enguehard, Cecile,Gueiffier, Alain
, p. 1631 - 1635 (2001)
This work reports the synthesis and the antiviral activities of 3-benzamido, 3-phenylureido and 3-phenylthioureido derivatives in the imidazo[1,2-a]pyridine series. The structure was proven by NMR spectroscopy. The synthesized compounds were evaluated against a large number of viruses. The 3-phenylthioureido derivative 7 showed moderate activity against human cytomegalovirus (HCMV) in vitro. The crystallographic data for 8 are also reported and explain the absence of activity against human immunodeficiency virus (HIV).
New pyrazole derivatives as CRAC channel modulators
-
, (2015/03/28)
The present invention relates to compounds of formula (I) which are inhibitors of CRAC channel activity. This invention also relates to pharmaceutical compositions containing them, process for their preparation and their use in therapy.
